Does DAPAGLIFLOZIN Cause Hyperkalaemia? 298 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 298 reports of Hyperkalaemia have been filed in association with DAPAGLIFLOZIN (QTERN). This represents 1.4% of all adverse event reports for DAPAGLIFLOZIN.
298
Reports of Hyperkalaemia with DAPAGLIFLOZIN
1.4%
of all DAPAGLIFLOZIN reports
13
Deaths
147
Hospitalizations
How Dangerous Is Hyperkalaemia From DAPAGLIFLOZIN?
Of the 298 reports, 13 (4.4%) resulted in death, 147 (49.3%) required hospitalization, and 79 (26.5%) were considered life-threatening.
Is Hyperkalaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DAPAGLIFLOZIN. However, 298 reports have been filed with the FAERS database.
What Other Side Effects Does DAPAGLIFLOZIN Cause?
Death (2,775)
Diabetic ketoacidosis (1,773)
Acute kidney injury (982)
Off label use (891)
Nausea (884)
Dehydration (860)
Vomiting (838)
Dizziness (817)
Ketoacidosis (803)
Fatigue (785)
What Other Drugs Cause Hyperkalaemia?
METFORMIN (2,565)
SPIRONOLACTONE (2,518)
FUROSEMIDE (2,035)
RAMIPRIL (1,383)
SACUBITRIL\VALSARTAN (1,192)
SULFAMETHOXAZOLE\TRIMETHOPRIM (1,036)
LISINOPRIL (948)
POTASSIUM (944)
BISOPROLOL (850)
TACROLIMUS (713)
Which DAPAGLIFLOZIN Alternatives Have Lower Hyperkalaemia Risk?
DAPAGLIFLOZIN vs DAPAGLIFLOZIN PROPANEDIOL
DAPAGLIFLOZIN vs DAPAGLIFLOZIN PROPANEDIOL\METFORMIN
DAPAGLIFLOZIN vs DAPRODUSTAT
DAPAGLIFLOZIN vs DAPSONE
DAPAGLIFLOZIN vs DAPTOMYCIN